Andy Doraiswamy
About Andy Doraiswamy
Andy Doraiswamy is the Founder and CEO of Koya Medical, Inc., and has held various leadership roles in healthcare innovation, including Co-founder and Chairman of Aquea Health, Inc. He has developed sight-restoring implants used by millions and holds advanced degrees in biomedical engineering, materials science, and chemical engineering.
Work at Koya Medical
Andy Doraiswamy serves as the Founder and CEO of Koya Medical, Inc., a position he has held since 2018. Under his leadership, Koya Medical focuses on innovative healthcare solutions, specifically targeting unmet medical needs. His extensive experience in the medical field contributes to the company's mission of improving patient outcomes.
Current Roles and Board Positions
In addition to his role at Koya Medical, Andy Doraiswamy is actively involved in several organizations. He has been a Board Director at OnPoint Vision, Inc. since 2019 and serves as a Board Advisor at the University of North Carolina at Chapel Hill School of Medicine since 2021. He is also a Co-founder and Chairman at Aquea Health, Inc. since 2020 and Rivermark Medical, Inc. since 2021.
Education and Expertise
Andy Doraiswamy holds a Doctor of Philosophy (PhD) in Biomedical/Medical Engineering from the University of North Carolina at Chapel Hill. He also earned a Master of Science (M.S.) in Materials Science and Engineering from the University of Arizona and a Bachelor of Technology (B.Tech.) in Chemical Engineering from the University of Madras. His educational background supports his expertise in healthcare innovation and medical technology.
Professional Background
Andy Doraiswamy has a diverse professional background in the medical technology sector. He previously worked as a Board Director at Enso Relief from 2017 to 2019 and at SEE International from 2014 to 2020. His experience includes serving as COO at Oculeve, where he led the development of a neuromodulation platform that was later acquired by Allergan Plc. He also held the position of Executive Director at Allergan for one year.
Innovations and Contributions
Andy Doraiswamy has made significant contributions to the field of healthcare innovation. He invented sight-restoring intraocular implants that have been utilized by over 6 million patients globally. This technology was acquired by Santen Pharmaceuticals and licensed to Bausch & Lomb. He holds numerous patents and publications, reflecting his commitment to advancing medical technology.